Glaxo shares slide on earnings blow

GlaxoSmithKline’s difficult year continued today as shares tumbled on a warning that it no longer expects to improve a key measure of earnings.

Glaxo shares slide on earnings blow

GlaxoSmithKline’s difficult year continued today as shares tumbled on a warning that it no longer expects to improve a key measure of earnings.

The drugs giant, which has been at the centre of a bribery probe by Chinese authorities, has been hit by a 10% fall in drug and vaccine sales in the United States, driven by competition from generic products.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited